GX EJ7 (Epivir 300 mg)
Generic Name: lamivudine
Pill with imprint GX EJ7 is Gray, Four-sided and has been identified as Epivir 300 mg. It is supplied by GlaxoSmithKline.
Epivir is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GX EJ7
Epivir
- Generic Name:
- lamivudine
- Imprint:
- GX EJ7
- Strength:
- 300 mg
- Color:
- Gray
- Size:
- 17.00 mm
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- GlaxoSmithKline
- Inactive Ingredients:
- ferric oxide black
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.
More about Epivir (lamivudine)
- Epivir Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review
- Generic Availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
